Standardized Treatment of Pulmonary Exacerbations II (STOP2)

About this Trial

This randomized, controlled, open-label study is designed to evaluate the efficacy and safety of differing durations of IV treatment, given in the hospital or at home for a pulmonary exacerbation in adult patients with CF.

• Status: Enrolling now
• Location: Miami Valley Hospital
• Study type: Interventional
• Ages eligible for study: 18 and older
• Genders eligible for study: Both
• Principal Investigator: Hari, Polenakovik, MD
• For more information about this study, visit ClinicalTrials.gov: NCT02781610

Contact us

If you would like information about participating in this study, contact:

Linda Clark
(937) 208-2913
lclark@premierhealth.com